Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023
- PMID: 40379263
- PMCID: PMC12086923
- DOI: 10.1136/bmjresp-2024-002572
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023
Abstract
Background: Recent reports highlight the importance of acute lower respiratory tract disease (aLRTD) for patients, but data describing incidence and burden in emergency departments (ED) are lacking.
Methods: A cohort study ascertaining cases prospectively at two EDs in Bristol, UK, enrolling adults (≥18 years) presenting with aLRTD from 1 August 2022 to 31 July 2023. Multivariate logistic regression modelled risk of hospitalisation. Incidence was estimated per 1000 person-years, using adult population estimates for the AvonCAP study catchment area.
Results: 151 865 ED visits, with 9452 (6.2%) aLRTD cases: 2376 (25%) were discharged and 7076 (75%) subsequently hospitalised, including:3663 (38.8%) pneumonia, 4167 (44.1%) non-pneumonic lower respiratory tract infection and 1622 (17.2%) cases without evidence of infection. Univariate analysis demonstrated that aLRTD patients discharged were younger than those hospitalised (median age 43.4 years, IQR 29.4-62.3 vs 74.0 years, IQR 59.8-83.5), and less likely to have pneumonia (17.0% vs 46.0%, respectively). Smoking, heart failure at presentation and underlying chronic cardiac disease conferred risk of admission, above an age effect in the adjusted logistic regression model.Total ED aLRTD incidence was 12.8/1000 person-years (9.6 admitted, 3.2 seen and discharged), with incidences of 7.0 and 36.8/1000 person-years in 18-64 years and ≥65 years, respectively, and incidence increased with patient age: 39.5 and 82.5/1000 person-years in 75-84 years and ≥85 years age groups, respectively.
Interpretation: We report a higher ED aLRTD incidence than in recent British Thoracic Society and Getting It Right First Time reports. This is concerning, particularly in older adults, and may be reduced by respiratory disease optimisation and public health initiatives including smoking cessation and vaccination programmes.
Keywords: Pneumonia; Respiratory Infection.
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Conflict of interest statement
Competing interests: CH is principal investigator of the AvonCAP study which is a university-guided collaboration between the University of Bristol (sponsor) and Pfizer (funder) and has previously received support from the NIHR in an Academic Clinical Fellowship. JO is a Co-Investigator on the AvonCAP Study. LD is further supported by UKRI through the JUNIPER consortium (grant number MR/V038613/1), MRC (grant number MC/PC/19067), EPSRC (EP/V051555/1 and The Alan Turing Institute, grant EP/N510129/1). AF is a member of the UK Joint Committee on Vaccination and Immunisation (JCVI). In addition to receiving funding from Pfizer as Chief Investigator of this study, he leads another project investigating transmission of respiratory bacteria in families jointly funded by Pfizer and the Gates Foundation and is an investigator in recent trials of COVID19 vaccines including ChAdOx1nCOV-19, Janssen and Valneva vaccines. The AvonCAP is conducted as a university-guided collaboration between the University of Bristol (sponsor) and Pfizer (funder). ML, EB, JS, JC, CT, GE and BDG are employees of Pfizer and may own Pfizer stock. The other authors have no relevant conflicts of interest to declare.
Figures


Similar articles
-
Predicting paediatric pneumonia severity in the emergency department: a multinational prospective cohort study of the Pediatric Emergency Research Network.Lancet Child Adolesc Health. 2025 Jun;9(6):383-392. doi: 10.1016/S2352-4642(25)00094-X. Lancet Child Adolesc Health. 2025. PMID: 40379430
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology.BMJ Open. 2022 Jun 15;12(6):e057464. doi: 10.1136/bmjopen-2021-057464. BMJ Open. 2022. PMID: 35705333 Free PMC article.
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
References
-
- NHS England Clinical policy: respiratory disease. 2024. [11-Apr-2024]. https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/ Available. Accessed.
-
- British Thoracic Society The cold facts: the impact of lung disease on A&E attendance and hospital admissions. 2018. [11-Apr-2024]. https://www.brit-thoracic.org.uk/media/70464/data-factsheet-winter-press... Available. Accessed.
-
- NHS England Hospital accident and emergency activity, 2022-23. 2023. [11-Apr-2024]. https://digital.nhs.uk/data-and-information/publications/statistical/hos... Available. Accessed.
-
- Mouton C, Mann C. NHS England and NHS Improvement; 2021. Emergency medicine: GIRF programme national specialty report.
MeSH terms
LinkOut - more resources
Full Text Sources